Statistics
Publications
1
Citations
13
H-Index
1
Active since
2009
Affiliations
University of Colorado Denver(Current)
D.S. Hong is an author at University of Colorado Denver specializing in pharmacokinetics of anticancer drugs, pharmacokinetics in children with cancer, and pi3k signaling.
Publications per year
2009–2009
1
1
Phase I trial of PX-866, a novel phosphoinositide-3-kinase (PI-3K) inhibitor
Antonio Jimeno, D.S. Hong, Sally E Hecker et al. · Journal of Clinical Oncology · 2009 · 13 citations
Medicine, Oncology, Pharmacology +15
1–1 of 1